Back
NovoCure Quote, Financials, Valuation and Earnings

Is it possible to have a crash proof portfolio?
See important Reg A disclosures: Masterworks.com/cd
Sell
44
NVCR
NovoCure
Last Price:
57.10
Seasonality Move:
31.19%
7 Day Trial
ALL ACCESS PASS
$
7

Ready For A Once In A Generation Opportunity In The Copper Space?
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!NovoCure Price Quote
$57.10
NovoCure Key Stats
Sell
44
NovoCure (NVCR)
is a Sell
Day range:
$56.52 - $60.42
52-week range:
$56.39 - $120.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.11
P/B ratio:
13.65%
Volume:
1.5M
Avg. volume:
649.8K
1-year change:
-25.63%
Market cap:
$6B
Revenue:
$537.8M
EPS:
$-0.88
How Much Does NovoCure Make?
Is NovoCure Growing As A Company?
NovoCure Stock Price Performance
What Is NovoCure 52-Week High & Low?
NovoCure Price To Free Cash Flow
-
Is NovoCure Stock Overvalued?
NovoCure is trading at a price to free cash flow ratio of 633.79 -
Is NovoCure Stock Undervalued?
NovoCure EV to Free Cash Flow ratio is 595.71 -
What Is NovoCure’s Price Earnings Growth Ratio?
NVCR PEG ratio is -1.14 -
Is NovoCure Trading At A Premium To Earnings?
NovoCure EV to EBIT ratio is 0.00
Is It Risky To Buy NovoCure?
Is NovoCure Cash Flow Positive?
NovoCure Return On Invested Capital
NovoCure Earnings Date & Stock Price
-
What Is NovoCure's Stock Price Today?
A single share of NVCR can be purchased today for 57.10 -
What Is NovoCure’s Stock Symbol?
NovoCure trades on the nasdaq under the ticker symbol: NVCR -
When Is NovoCure’s Next Earnings Date?
The next quarterly earnings date for NovoCure is scheduled on April 28, 2023 -
When Is NVCR's next ex-dividend date?
NovoCure's next ex-dividend date is March 20, 2023 -
How To Buy NovoCure Stock?
You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
NovoCure Competitors
NovoCure Dividend Yield
Data Unavailable
NovoCure Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -15.31% |
Revenue: | -3.59% | 0.76% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 2 |
Price Target: | 96.75 |
Upside from Last Price: | 69.44% |